Resultados de la búsqueda 1-10 of 15062 for armodafinil

  1. Mayo Clinic Neurosciences Physician Update — May 2025

    Page 1.

  2. Alimentación mediterránea para la salud del corazón. - Mayo Clinic

    clbemp-bu;="3ccm999od,Column--e="32x3hdf25.707 13.707L4.t.)ochevrmp-b//ta-cmplayer="{&quwida14 -atp://ta-c.wida14 f/spau/espuwida14 -atp://ta-c.wida14 ...

  3. Deficiencia de alfa-1 antitripsina

    Learn about alpha-1 antitrypsin deficiency. American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/alpha-1-antitrypsin- ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...